d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Second generation Braf inhibitor (after lead compound vemurafenib) in Braf mutated solid tumors, and extension phase in melanomas and colorectal cancer [Country] DK [Cancer type] 
Solide tumores
Nordic NECT - Inclusion completed
Cancer type